Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy

Radiotherapy and Oncology

Volumn 73, Issue 1, 2004, Pages 39-48

  Wust, Peter ^a   Von Borczyskowski, Daniel Wischka ^a,b   Henkel, Thomas ^b   Rosner, Christian ^a   Graf, Reinhold ^a   Tilly, Wolfgang ^a   Budach, Volker ^a   Felix, Roland ^a   Kahmann, Frank ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Mariendorfer Damm 1 12099 B ^*  (Germany)

Author keywords

125 I seed implantation; Correlation analysis; Early prostate cancer; Postimplantation analysis; Toxicity spectrum

Indexed keywords

IODINE 125;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BLADDER DISEASE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CHRONIC TOXICITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSIMETRY; DYSURIA; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; POTENCY DISORDER; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION INJURY; RECTUM DISEASE; SCORING SYSTEM; SEXUAL DYSFUNCTION; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING; URINARY TRACT DISEASE; URINARY TRACT OBSTRUCTION; URINE CATHETER;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 4644248268     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.08.003     Document Type: Article

References (36)

1. J.J. Battermann, T.A. Boon, and M.A. Moerland Results of permanent prostate brachytherapy, 13 years o experience at a single institution Radiother Oncol 71 2004 23 28
2. C.B. Begg, E.R. Riedel, and P.B. Bach Variations in morbidity after radical prostatectomy N Engl J Med 346 2002 1138 1144
3. D. Brown, A. Colonais, and R. Miller Urinary morbidity with a modified peripheral loading technique of transperineal I-125 prostate implantation Int J Radiat Oncol Biol Phys 47 2000 353 360
4. P.R. Carroll, K.L. Lee, Z.Y. Fuks, and P.W. Kantoff Cancer of the prostate V.T. DeVita S. Hellman S.A. Rosenberg Cancer. Principles and practice of oncology 6th ed 2001 Lippincott Williams & Wilkins Philadelphia, PA 1418
5. J. Crook, M. McLean, C. Catton, I. Yeung, J. Tsihlias, and M. Pintilie Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation Int J Radiat Oncol Biol Phys 52 2002 453 460
6. W. D'Souza, and R.R. Meyer Dose homogeneity as a function of source activity in optimized I-125 prostate implant treatment plans Int J Radiat Oncol Biol Phys 51 2001 1120 1130
7. 125I brachytherapy Int J Radiat Oncol Biol Phys 51 2001 31 40
8. T.W. Kaulich, U. Lamprecht, and F. Paulsen Physikalische Grundlagen und klinische Durchführung der interstitiellen Brachytherapie der Prostata mit Jod-125 Strahlenth Onkol 178 2002 548 555
9. P.A. Kupelian, L. Potters, and D. Khuntia Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≤72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-2 prostate cancer Int J Radiat Oncol Biol Phys 58 2004 25 33
10. C.A. Lawton, M. Won, and M.V. Pilepich Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706 Int J Radiat Oncol Biol Phys 21 1991 935 939
11. G.S. Lederman, W. Cavanagh, and P.S. Albert Retrospective stratification of a consecutive cohort of prostate cancer patients treated with a combined regimen of external-beam radiotherapy and brachytherapy Int J Radiat Oncol Biol Phys 49 2001 1297 1303
12. W.R. Lee, G.E. Hanks, A.L. Hanlon, T.E. Schultheiss, and M.A. Hunt Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect Int J Radiat Oncol Biol Phys 35 1996 251
13. W. Lilleby, S.D. Fossa, H.R. Waehre, and D.R. Olsen Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy Int J Radiat Oncol Biol Phys 43 1999 735 743
14. P.D. Maguire, F.M. Waterman, and A.P. Dicker Can the cost of permanent prostate implants be reduced? An argument for peripheral loading with higher strength seeds Tech Urol 6 2000 85 88
15. P. Mangili, L. Stea, and F. Cattani Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes Radiother Oncol 71 2004 13 21
16. G.S. Merrick, W.M. Butler, A.T. Dorsey, R.W. Galbreath, H. Blatt, and J.H. Lief Rectal function following prostate brachytherapy Int J Radiat Oncol Biol Phys 48 2000 667 674
17. G.S. Merrick, W.M. Butler, R.W. Galbreath, R.L. Stipetich, L.J. Abel, and J.H. Lief Erectile function after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 52 2002 893 902
18. G.S. Merrick, W.M. Butler, and K.E. Wallner Dysuria after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 55 2003 979 985
19. S. Nag, D. Beyer, J. Friedland, P. Grimm, and R. Nath American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 1999 789 799
20. S. Nag, and W. Bice The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis Int J Radiat Biol Oncol Phys 46 2000 221 230
21. S. Nag, R.J. Ellis, and G.S. Merrick American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy Int J Radiat Oncol Biol Phys 54 2002 462 470
22. J.J. Pavy, J. Denekamp, and J. Letschert LATE effects toxicity scoring: the SOMA scale Radiother Oncol 35 1995 11 15
23. R.E. Peschel, and J.W. Colberg Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer Lancet Oncol 4 2003 233 241
24. L. Potters, T. Torre, P.A. Fearn, S.A. Leibel, and M.W. Kattan Potency after permanent prostate brachytherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 50 2001 1235 1242
25. L. Potters, E.A. Klein, and M.W. Kattan Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation Radiother Oncol 71 2004 29 33
26. H. Radge, and A.A. Elgamal Ten-year disease free survival after transperineal sonography-guided Iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma Cancer 83 1998 989 1000
27. N. Salem, M. Simonian-Sauve, and R. Rosello Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 study Radiother Oncol 66 2003 159 165
28. T.E. Schultheiss, W.R. Lee, M.A. Hunt, A.L. Hanlon, R.S. Peter, and G.E. Hanks Late GI and GU complications in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 37 1997 3 11
29. T. Sherertz, K. Wallner, H. Wang, S. Sutlief, and K. Russell Long-term urinary function after transperineal brachytherapy for patients with large prostate glands Int J Radiat Oncol Biol Phys 51 2001 1241 1245
30. R.S. Sloboda, J.E. Pedersen, and R. Halperin Is there a preferred strength for regularly spaced 125-I-Seeds in inverse-planned prostate implants? Int J Radiat Oncol Biol Phys 55 2003 234 244
31. K.M. Snyder, R.G. Stock, S.M. Hong, Y.C. Lo, and N.N. Stone Defining the risk of developing grade 2 proctitis following 125-I prostate brachytherapy using a rectal dose-volume histogram analysis Int J Radiat Oncol Biol Phys 50 2001 335 341
32. G. Steineck, F. Helgesen, and A. Adolfsson Quality of life after radical prostatectomy or watchful waiting N Engl J Med 347 2002 790 796
33. R.G. Stock, N.N. Stone, and C. Iannuzzi Sexual potency following interactiv ultrasound guided brachytherapy for prostate cancer Int J Radiat Oncol Biol Phys 35 1996 267 272
34. R.G. Stock, N.N. Stone, Y.C. Lo, N. Malhado, J. Kao, and J.K. DeWyngaert Postimplant dosimetry for 125-I prostate implants: definitions and factors affecting outcome Int J Radiat Oncol Biol Phys 48 2000 899 906
35. F.M. Waterman, and A.P. Dicker Probability of late rectal morbidity in 125-I prostate brachytherapy Int J Radiat Oncol Biol Phys 55 2003 342 353
36. M.J. Zelefsky, Z. Fuks, and M. Hunt High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 53 2002 1111 1116